Product Developments Clause Samples

Product Developments. “Product Developments” means any and all inventions, discoveries, know-how, information, data, writings and other Intellectual and Industrial Property, in any form whatsoever, both tangible and intangible, developed by ERN or by Zavante in the course of performance under this Agreement that specifically relate to the Product, the API, or the API Mixture.

Product Developments. ALRT shall from time to time provide PARI with such up-to-date information concerning the Software as ALRT has available and as PARI may from time to time reasonably request.

Product Developments. With respect to the Services provided by Medarex that are clinical and regulatory support services ("Clinical/Regulatory Services"): (a) Medarex shall make full and prompt written disclosure to Celldex of all inventions, innovations, improvements, modifications, know-how, discoveries and developments, whether or not patentable or copyrightable (collectively, "Clinical/Regulatory IP"), that are conceived or reduced to practice by or under the direction of Medarex, alone or jointly with others, during the course of performing Clinical/Regulatory Services. (b) Celldex shall own all right, title and interest in and to any Clinical/Regulatory IP that is directly and solely related to the Celldex product that is the subject of such Clinical/Regulatory Services ("Celldex Product Developments"). Medarex shall execute assignments of ownership with respect to Celldex Product Developments and shall be responsible for obtaining assignments of ownership from third parties sufficient to transfer to or vest in Celldex the rights to Celldex Product Developments described in this Section 1.7(b), at no additional charge to Celldex. (c) For the avoidance of doubt, "Celldex Product Developments" shall not include Clinical/Regulatory IP that is conceived or reduced to practice by or under the direction of Medarex, alone or jointly with others, during the course of performing Clinical/Regulatory Services, where such Clinical/Regulatory IP is not related directly and solely to the Celldex product that is the subject of such Clinical/Regulatory Services ("Medarex Developments"). Medarex Developments include, without limitation, Medarex's methodologies or processes of conducting clinical studies and protocol development. As between Medarex and Celldex, subject to Sections 1.7(d) and 1.7(e), Medarex shall retain ownership of all right, title and interest in and to Medarex Developments. (d) In the event that a Medarex Development constitutes a Deliverable, Medarex shall grant, and does hereby grant, to Celldex a worldwide, royalty-free, nonexclusive, perpetual license, with the right to sublicense, to use such Medarex Development as reasonably necessary for Celldex to fully utilize such Deliverable. Promptly following the first disclosure, pursuant to Section 1.7(a), of a Medarex Development that constitutes a Deliverable, Medarex and Celldex shall enter into a license agreement containing all of the rights and responsibilities of the parties with respect to the license granted in t...

Product Developments. AvePoint shall keep Reseller reasonably informed about developments concerning the Solutions that may be useful to Reseller in the performance of this Agreement. AvePoint shall have the sole right to modify, alter, change, enhance, improve, or discontinue any or all of the Solutions at any time. In the event Reseller does not find the modified, altered, changed, enhanced, or improved Solutions to be acceptable, Reseller may terminate this Agreement pursuant to Section 11.2.

Product Developments. All Intellectual Property relating to a Product conceived, reduced to practice, authored or otherwise generated or developed in the course of activities under this Agreement, either by or on behalf of Supplier, except if it has general applicability to the manufacture of pharmaceutical products other than the Products (unless such Intellectual Property relates to and/or is an improvement, modification, alteration or enhancement to any of Purchaser Intellectual Property, in which case it shall be a Product Development), shall be "Product Developments". Purchaser shall own all right, title and interest in and to all Product Developments, whether made, conceived, reduced to practice, authored or otherwise generated or developed solely by Supplier personnel, or jointly by Supplier and Purchaser personnel, and all rights to Intellectual Property arising therefrom. Supplier will, and hereby does, assign to Purchaser all of its rights, title and interest in and to Product Developments and rights to Intellectual Property arising therefrom. Supplier will provide reasonable assistance to Purchaser, at Purchaser's expense, in obtaining and enforcing Purchaser's ownership of the Product Developments, including as applicable the assignment to Purchaser of the right, title and interest of Supplier's employees or independent contractors in and to such Product Developments.

Product Developments. All Intellectual Property relating to the Product conceived, reduced to practice, authored or otherwise generated or developed in the course of activities under this Agreement or the Development and Scale Up Agreement dated 05 May 2004, either by or on behalf of Jagotec, except if it has general applicability to the manufacture of pharmaceutical products, shall be “CRTX Product Developments”. CRTX shall own all right, title and interest in and to all CRTX Product Developments, whether made, conceived, reduced to practice, authored or otherwise generated or developed solely by Jagotec personnel, or jointly by CRTX and Jagotec personnel, and all rights to Intellectual Property arising therefrom. Jagotec will, and hereby does, assign to CRTX all of its rights, title and interest in and to CRTX Product Developments and rights to Intellectual Property arising therefrom. Jagotec will provide reasonable assistance to CRTX, at CRTX’s expense, in obtaining and enforcing CRTX’s ownership of the CRTX Product Developments, including as applicable the assignment to CRTX of the right, title and interest of Jagotec’s employees or independent contractors in and to such CRTX Product Developments. All Intellectual Property relating to the Product that has general applicability to the manufacture of pharmaceutical products (and therefore does not constitute CRTX Product Developments) and/or any developments to the Jagotec Intellectual Property resulting from the work conducted by Jagotec hereunder shall be “Jagotec Product Developments”. Jagotec shall own all right, title and interest in and to all Jagotec Product Developments, whether made, conceived, reduced to practice, authored or otherwise generated or developed solely by Jagotec personnel, or jointly by CRTX and Jagotec personnel, and all rights to Intellectual Property arising therefrom. CRTX will, and hereby does, assign to Jagotec all of its rights, title and interest in and to Jagotec Product Developments and rights to Intellectual Property arising therefrom. CRTX will provide reasonable assistance to Jagotec, at Jagotec’s expense, in obtaining and enforcing Jagotec’s ownership of the Jagotec Product Developments, including as applicable the assignment to Jagotec of any right, title and interest of CRTX’s employees or independent contractors in and to such Jagotec Product Developments.

Product Developments. New Product Opportunities At Purchasing Partners' request, Seller will meet with Purchasing Partners at least two (2) times during each year of this Agreement to share new product information and technology and to discuss opportunities of mutual interest. All expenses associated with such meetings during each year of this Agreement will be paid in a mutually agreed upon arrangement. Seller will work with Purchasing Partners and Participating Premier Members in developing new products and exploring opportunities for market research, clinical trials and technology transfer. Contemporaneous with Seller's announcement to any other customer of any new commercially available product, Seller will notify Purchasing Partners in writing of the nature, potential uses and performance specifications of such product.

Product Developments. All Intellectual Property relating to a Product conceived, reduced to practice, authored or otherwise generated or developed in the course of activities under this Agreement, either by or on behalf of Supplier, except if it has general applicability to the manufacture of pharmaceutical products other than the Products, shall be “Product Developments”. Purchaser shall own all right, title and interest in and to all Product Developments, whether made, conceived, reduced to practice, authored or otherwise generated or developed solely by Supplier personnel, or jointly by Supplier and Purchaser personnel, and all rights to Intellectual Property arising therefrom. Supplier will, and hereby does, assign to Purchaser all of its rights, title and interest in and to Product Developments and rights to Intellectual Property arising therefrom. Supplier will provide reasonable assistance to Purchaser, at Purchaser’s expense, in obtaining and enforcing Purchaser’s ownership of the Product Developments including as applicable the assignment to Purchaser of the right, title and interest of its employees or independent contractors in and to such Product Developments.

Product Developments. 4.1. Technical representatives of Zentek and ▇▇▇▇▇▇ shall meet regularly in order to identify and map any required updates and adjustments for existing Zentek Products or Ekomed Products, as well as explore new product development opportunities. 4.2. Each of Zentek and Ekomed shall use commercially reasonable efforts to implement any changes to the specifications of the Zentek Product or Ekomed Product, as applicable, that, from time to time, are necessary to ensure that the products are improved, updated and adjusted, in order to maintain a competitive product ("Ongoing Advancement Services"). If additional advance time would reasonably be required in order to implement the manufacturing or development processes for supply of a Zentek Product or Ekomed Product, as applicable, with any changed or additional specifications, and to commence manufacture thereof, the Parties shall notify the other.